There may be several reasons for this usefulness of tofacitimib treatment in BS but certainly one explanation might be that this drug inhibits not just TNF-alpha but appears to inhibit IL-1, IL-6, and IFN-gamma cytokines. Here, IFNG is linked to Bloom syndrome.